The classification of depressions.

A. Whitehead

DOI: https://doi.org/10.1192/BJP.129.5.510B

1976-11-01

Abstract:

What problem does this paper attempt to address?

Understanding the experiences of lung volume recruitment among boys with Duchenne muscular dystrophy: A multicenter qualitative study

Sherri L Katz,Henrietta Blinder,Dennis Newhook,Leana Azerrad Bmus,Stuart Nicholls,Hugh J McMillan,Jean K Mah,Craig Campbell,Laura C McAdam,David Zielinski,Karine Toupin-April,Franco Momoli,Douglas A McKim

DOI: https://doi.org/10.1002/ppul.26154

Abstract:Background: Despite recommendations for regular lung volume recruitment (LVR) use in clinical practice guidelines for children with neuromuscular disease, adherence to LVR is poor. We aimed to describe the experience of LVR by boys with Duchenne muscular dystrophy (DMD), their families, and healthcare providers (HCPs), as well as to identify the barriers and facilitators to LVR use. Methods: This multicenter, qualitative study evaluated boys with DMD (n = 11) who used twice-daily LVR as part of a randomized controlled trial, as well as their parents (n = 11), and HCPs involved in the clinical use of LVR (n = 9). Semistructured interviews were conducted to identify participants' understanding of LVR therapy and their beliefs, barriers and facilitators to its use. Thematic analysis was conducted using an inductive approach. A subanalysis compared adherent and nonadherent children. Results: Seven themes were identified related to participants' beliefs and experiences with LVR: emotional impact, adaptation to LVR, perceived benefits of LVR, routine, family engagement, clinical resources, and equipment-related factors. Strategies to improve adherence were also identified, including education, reinforcement and demonstration of LVR benefit, as well as clinician support. There were no thematic differences between adherent and nonadherent children. Discussion: Despite the benefits of LVR and positive experiences with it by many families, there remain barriers to adherence to treatment. HCPs need to balance the need for early introduction to give families time to adapt to LVR while ensuring that the benefit of LVR outweighs the burden. Clinician support is important for family engagement.
Duplex ultrasound evaluation of patients with chronic venous disease of the lower extremities.

N. Khilnani

DOI: https://doi.org/10.2214/AJR.13.11465

2014-02-20

Abstract:OBJECTIVE This article will describe the elements of performing a thorough venous ultrasound evaluation of the lower extremity in patients with manifestations of chronic venous disorder. The emphasis will be on the evaluation of superficial venous reflux. Only the specific aspects of the evaluation of the deep system pertaining to chronic venous disease will be discussed. CONCLUSION Duplex ultrasound requires the examiner to solve a puzzle to explain the patient's clinical manifestations. Patients who have been treated with surgery, thermal ablation, or ultrasound-guided sclerotherapy will require duplex ultrasound after treatment to identify complications, gauge the extent of treatment success, and evaluate the cause for any recurrence.
Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy

J C Raphael,S Chevret,C Chastang,F Bouvet

DOI: https://doi.org/10.1016/s0140-6736(94)93058-9

1994-06-25

Abstract:Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy in children. Paralysis of respiratory muscles causes a decrease in forced vital capacity (FVC) from age 12 years, and death occurs between 20 and 25 years old and is usually related to respiratory insufficiency. Uncontrolled studies suggest that early home use of nasal intermittent positive-pressure ventilation (NIPPV) in DMD patients free of respiratory failure could limit progression of the restrictive syndrome and therefore improve survival because efficacy of preventive NIPPV has not been demonstrated in a controlled trial, we undertook a randomised multicentre study in which 70 patients with DMD were included. Patients were free of daytime respiratory failure and FVC was between 20 and 50% of predicted values. At least 6 h of nocturnal NIPPV (n = 35) was compared with conventional treatment (n = 35). During a mean follow-up of 52 months, 10 patients died, 8 in the NIPPV group and 2 in the control group (p = 0.05, log-rank test). No differences were observed between the two groups for occurrence of hypercapnia, decrease of FVC below 20% of initial values, or use of necessary mechanical ventilation. Preventive NIPPV did not improve respiratory handicap and reduced survival of DMD patients. Use of NIPPV for preventive purposes should be avoided in patients with FVC between 20 and 50% of predicted values.
EFFECTS OF NA OPTIMIZED APPROACH TO HOME-BASED RESPIRATORY CARE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY: STUDY PROTOCOL FOR CLINICAL TRIAL

Ana Cristina de Medeiros Garcia Maciel,Guilherme Augusto de Freitas Fregonezi,Vanessa Regiane Resqueti,Tatiana Souza Ribeiro,Karen de Medeiros Pondofe,Rayane Grayce da Silva Vieira

DOI: https://doi.org/10.1016/j.bjpt.2024.100618

IF: 4.762

2024-04-01

Brazilian Journal of Physical Therapy

Abstract:Background Duchenne Muscular Dystrophy (DMD) is an inherited neuromuscular degenerative disease that leaves muscle fibers more susceptible to mechanical stress due to muscle contraction, leading to progressive muscle weakness resulting in decreased lung ventilation and an ineffective cough, favoring the onset of complications such as respiratory failure, the main cause of mortality. Management of patients with DMD aims to maintain respiratory function and involves all aspects of care, including at home. Objective This study aims to investigate the effects of an optimal home-based respiratory care protocol in individuals with DMD. Methods This is a randomized, blinded controlled trial involving patients with DMD, aged 7 years. Patients will be randomly allocated into the conventional respiratory care (CRC) and optimized respiratory care home-based (ORC) groups. Primary outcomes will be peak cough flow and number of exacerbations. Secondary outcomes will include chest wall volumes, maximal respiratory pressures, nasal inspiratory and expiratory pressure and forced vital capacity (FVC), forced expiratory volume in the 1st second (FEV1) and, FEV1 /FVC. The CRC group will receive education on respiratory care during quarterly hospital visits will consist of guidelines on positioning in bed and during fluid and food ingestion. The caregiver will be trained on aspirating the oral cavity secretions and assisting patients in coughing through air stacking by manual ventilation with a bag and an oronasal mask when needed. The ORC group will receive education on respiratory care during quarterly hospital visits and weekly home visits by a physiotherapist. During the visit, the physiotherapist will provide settings to use and improve non-invasive ventilation, aspiration of upper airways and assisted coughing through air stacking. Both groups will receive weekly telephone calls to monitor patients and provide assistance to minimize complications and exacerbations. All caregivers will be trained to monitor vital signs and peripheral oxygen saturation. A 6-month intervention is planned, the outcomes will be assessed every 3 months, and 3- and 6-month follow-up after the final evaluation. Results The primary and secondary results will be described as average or median for continuous variables and absolute and relative frequencies for qualitative variables. Treatment effects or differences between the outcomes (baseline, 3 months, and 6 months) of the study groups will be analyzed using an analysis of variance. The level of significance will be set as p≤0.05. Conclusion individuals with DMD have respiratory complications that gradually worsen and may culminate in death. These patients should receive regular daily respiratory care and assistance from caregivers and family members, as well as professional follow-up to reduce exacerbations. The challenges associated with public health care for patients, as well as the lack of knowledge among health professionals and the community, favor the worsening of DMD and, consequently, the increase in hospitalizations and public spending. Implications We hope that the study can demonstrate the importance of home physiotherapy with specialized assistance, which will provide comfort and safety to patients and their families. We believe that a well-implemented therapeutic program will reduce morbidity and mortality rates in patients with DMD.

rehabilitation,orthopedics
Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy: A Single-Site Retrospective Longitudinal Study

Federica Trucco,Joana P Domingos,Chee Geap Tay,Deborah Ridout,Kate Maresh,Pinki Munot,Anna Sarkozy,Stephanie Robb,Rosaline Quinlivan,Mollie Riley,Michael Burch,Matthew Fenton,Colin Wallis,Elaine Chan,Francois Abel,Adnan Y Manzur,Francesco Muntoni

DOI: https://doi.org/10.1016/j.chest.2020.04.043

IF: 9.6

Chest

Abstract:Background: Corticosteroids (CSs) have prolonged survival and respiratory function in boys with Duchenne muscular dystrophy (DMD) when compared with CSs-naïve boys. Research question: The differential impact of frequently used CSs and their regimens on long-term (> 5 years) cardiorespiratory progression in children with DMD is unknown. Study design and methods: This was a retrospective longitudinal study including children with DMD followed at Dubowitz Neuromuscular Centre, Great Ormond Street Hospital London, England, from May 2000 to June 2017. Patients enrolled in any interventional clinical trials were excluded. We collected patients' anthropometrics and respiratory (FVC, FVC % predicted and absolute FVC, and noninvasive ventilation requirement [NIV]) and cardiac (left ventricular shortening function [LVFS%]) function. CSs-naïve patients had never received CSs. Patients who were treated with CSs took either deflazacort or prednisolone, daily or intermittently (10 days on/10 days off) for > 1 month. Average longitudinal models were fitted for yearly respiratory (FVC % predicted) and cardiac (LVFS%) progression. A time-to-event analysis to FVC % predicted < 50%, NIV start, and cardiomyopathy (LVFS% < 28%) was performed in CS-treated (daily and intermittent) vs CS-naïve patients. Results: There were 270 patients, with a mean age at baseline of 6.2 ± 2.3 years. The median follow-up time was 5.6 ± 3.5 years. At baseline, 263 patients were ambulant. Sixty-six patients were treated with CSs daily, 182 patients underwent CSs intermittent > 60% treatment, and 22 were CS-naïve patients. Yearly FVC % predicted declined similarly from 9 years (5.9% and 6.9% per year, respectively; P = .27) in the CSs-daily and CSs-intermittent groups. The CSs-daily group declined from a higher FVC % predicted than the CSs-intermittent group (P < .05), and both reached FVC % predicted < 50% and NIV requirement at a similar age, > 2 years later than the CS-naïve group. LVFS% declined by 0.53% per year in the CSs-treated group irrespective of the CSs regimen, significantly slower (P < .01) than the CSs-naïve group progressing by 1.17% per year. The age at cardiomyopathy was 16.6 years in the CSs-treated group (P < .05) irrespective of regimen and 13.9 years in the CSs-naïve group. Interpretation: CSs irrespective of the regimen significantly improved respiratory function and delayed NIV requirement and cardiomyopathy.
Respiratory Function and Sleep Disordered Breathing in Pediatric Duchenne Muscular Dystrophy

Alberto A Zambon,Federica Trucco,Aidan Laverty,Mollie Riley,Deborah Ridout,Adnan Y Manzur,Francois Abel,Francesco Muntoni

DOI: https://doi.org/10.1212/WNL.0000000000200932

IF: 9.9

2022-09-20

Neurology

Abstract:Background and objectives: The decline of respiratory function in Duchenne muscular dystrophy (DMD) is associated with sleep disordered breathing (SDB) and alteration of nocturnal gas exchange, first manifesting as nocturnal hypoventilation (NH). However, the correlation between the pulmonary function measured by spirometry (PFT) and the onset of SDB with or without NH is unclear. The aims of this study are to identify the prevalence and features of SDB and to investigate the relationship between lung function determined by forced vital capacity (FVC) and sleep abnormalities in a large pediatric DMD population. Methods: This was a retrospective, single-center cohort study. FVC% predicted (FVC%) was calculated using predicted equations from the Global Lung Function Initiative. NH was defined by transcutaneous (tc) CO2 >50 mm Hg for >25% of total sleep time (TST), borderline NH by a mean tcCO2 between 45 and 50 mm Hg or tcCO2>50 mm Hg for ≤25% of TST, and clinically meaningful obstructive sleep apnea (OSA) by obstructive apnea-hypopnea index >5. The sensitivity, specificity, and positive and negative predictive values of FVC < 50% to indicate the presence of nocturnal hypoventilation were calculated. Results: One hundred thirty-four patients underwent 284 sleep studies and 1222 PFT. The mean (SD) age at the first and the last sleep study was 12.9 (2.7) and 14.3 (2.6) years, respectively. Borderline NH (n = 31) was detected in both ambulant and early-nonambulant participants, while 100% of NH cases (n = 14) were nonambulant. NH was detected in 4 of the 14 patients despite an FVC >50%. Seventeen of the 26 patients with OSA presented with concomitant NH or borderline NH. FVC <50% was associated with NH indicating a sensitivity and specificity of 73% and 86%, respectively. Positive and negative predictive values were 32% and 97%, respectively. PFT showed a nonlinear, sudden FVC% decline in 18% of cases. Discussion: FVC% <50 was associated with NH in close to a third of patients. CO2 elevation can be associated with obstructive/pseudo-obstructive events and was also observed in early nonambulant cases or in the presence of FVC >50%. These results are relevant for the clinical management of SDB.
Lung volume recruitment improves volitional airway clearance in amyotrophic lateral sclerosis

Stuart Cleary,John E Misiaszek,Sonya Wheeler,Sanjay Kalra,Shelagh K Genuis,Wendy S Johnston

DOI: https://doi.org/10.1002/mus.27417

Abstract:Introduction/aims: In this study we evaluated the effects of lung volume recruitment treatment (LVR), a low-tech, low-cost, manual "breath-stacking" technique used to help people cough with enough force to clear their airways, thereby reducing the risk of aspiration and choking, on five volitional airway clearance and protection behaviors used by people living with amyotrophic lateral sclerosis (PwALS). Methods: Using a repeated-measures cross-over design, 29 PwALS performed five volitional airway clearance and protection behaviors in LVR treatment and in no-treatment, control conditions. Peak cough flow (PCF) was used to measure maximum expiratory rate during forced expiration, throat clearing, hawking, post-swallow coughing, and the supraglottic swallowing maneuver. Comparisons were made as a function of condition (treatment or control) and three time-points (pretreatment, and 15 and 30 minutes posttreatment). Results: LVR treatment had a significant positive effect on maximum expiratory rates during all tested airway clearance and protection behaviors. Increased PCF values lasted for up to 30 minutes post-LVR for all tested behaviors in the treatment condition. Discussion: We found that LVR treatment could increase control over airway clearance in PwALS, as well as provide improved airway protection for up to 30 minutes, the duration of a typical meal. This study has implications for patient care. These include offering patients control over some of the most feared symptoms of ALS, particularly choking during activities of daily living, and enhanced ALS respiratory care in low-resource settings. Findings may have implications for other neurodegenerative disorders in which dysphagia occurs with retained sensory function.
Brainstem neurons expressing c-Fos immunoreactivity following irritant chemical stimulation of the rat's tongue

E. Carstens,I. Saxe,R. Ralph

DOI: https://doi.org/10.1016/0306-4522(95)00297-V

IF: 3.708

1995-12-01

Neuroscience

Abstract:
Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience

M Toussaint,M Chatwin,P Soudon

DOI: https://doi.org/10.1177/1479972307080697

Abstract:Chronic respiratory insufficiency is inevitable in the course of disease progression in patients with Duchenne muscular dystrophy (DMD). Without mechanical ventilation (MV), morbidity and mortality are highly likely towards the end of the second decade of life. The present review reports evidence and clinical implications regarding DMD patients treated with MV. There is no doubt that nocturnal hypercapnia precedes daytime hypercapnia. Historical comparisons have provided evidence that non-invasive intermittent positive pressure ventilation (NIPPV) at night is effective and improves quality of life and survival by 5-10 years. By contrast, the optimal criteria and timing for initiation of NIPPV are inconsistent. A recent randomized study however demonstrated the benefits of commencing NIPPV as soon as nocturnal hypoventilation is detected (Ward S, et al., Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019-24). The respective role of the three hypotheses of the indirect action of nocturnal NIPPV on daytime blood gases may be complimentary; the main improvement may be due to improved ventilatory response to CO2. The ultimate time to offer full time ventilation with the most advantageous interface is lacking in evidence. Full time NIV is possible with a combination of a nasal mask during the night and a mouthpiece during the day, however tracheostomy may be provided when mechanical techniques of cough-assistance are useless to treat chronic cough insufficiency.
Non-invasive ventilation usage and adherence in children and adults with Duchenne muscular dystrophy: A multicenter analysis

Manju Hurvitz,Kanokkarn Sunkonkit,Andrew Defante,Daniel Lesser,Andrew Skalsky,Jeremy Orr,Abhishek Chakraborty,Reshma Amin,Rakesh Bhattacharjee

DOI: https://doi.org/10.1002/mus.27848

Abstract:Introduction/aims: Non-invasive ventilation (NIV) is routinely prescribed to support the respiratory system in Duchenne muscular dystrophy (DMD) patients; however, factors improving NIV usage are unclear. We aimed to identify predictors of NIV adherence in DMD patients. Methods: This was a multicenter retrospective analysis of DMD patients prescribed NIV and followed at (1) The Hospital for Sick Children, Canada; (2) Rady Children's Hospital San Diego, USA; and (3) University of California San Diego Health, USA, between February 2016 and October 2020. The primary and secondary outcomes were 90-day period NIV adherence and clinical and socioeconomic predictors of NIV adherence. Results: We identified 59 DMD patients prescribed NIV (mean ± SD age = 20.1 ± 6.7 y). Overall, percentage of nights used, and average nightly usage, were 79.9 ± 31.1% and 7.23 ± 4.12 h, respectively. Compared with children, adults had higher percentage of nights used (92.9 ± 16.9% vs. 70.4 ± 36.9%; P < .05), and average nightly usage (9.5 ± 4.7 h vs. 5.3 ± 3.7 h; P < .05). Non-English language (P = .01), and absence of deflazacort prescription (P = .02) were significantly associated with higher percentage of nights used while Hispanic ethnicity (P = .01), low household income (P = .02), and absence of deflazacort prescription (P = .02) were significantly associated with higher nightly usage. Based on univariable analysis, older age and declining forced vital capacity were associated with increased percentage of nights used and increased average nightly usage. Discussion: Certain clinical and socioeconomic determinants had a significant impact on NIV adherence in DMD patients, providing insight into those at risk for high versus low compliance with respiratory therapy.
A new structure for VLSI bipolar technology

P. Seegebrecht,Wonchan Kim

DOI: https://doi.org/10.1109/IEDM.1979.189574

Abstract:A novel bipolar process which is complementary to the collector diffused isolation (CDI) process but compatible with the standard buried collector (SBC) process will be presented. The application of it to ECL. and I2L circuits show the advantages of small circuit size and improved performance.
Problems in Child Neurology and Psychology

R. Leys

DOI: https://doi.org/10.1111/j.1469-8749.1962.tb03107.x

1962-02-01

Developmental Medicine & Child Neurology

Abstract:CHILDREN with intellectual and educational handicaps that are not accompanied by any clear-cut neurological deficits can present problems to both psychologist and neurologist, and there is a wide diversity of opinion as to their origin. In some respects such cases challenge the traditional dichotomy which has grown up between psychology and neurology: they do not easily fit into the conceptual model of psychiatry, with its emphasis on early instinctual and emotional development, neither are they easily assimilated into clinical neurology. Some look on these intellectual and educational handicaps as essentially an emotional affair, while others find the idea of an emotional holdup inadequate. It is certainly worth exploring the possibility that there is an organic basis to these disabilities, though the approach in this field has been limited both by speculative theories of brain function and by too little regard for the educational issues. In his talk to the Association for Child Psychology and Neurology on November 8 , on Common Problems in Child Neurology and Psychologj., Prof. 0. L. Zangwill described cases of children who have a good verbal I.Q. but a poor visual performance. At school, such children are often poor at mathematics, science and geography, though good at languages: they are clumsy without being apraxic; they are poor at practical skills; they are often left-handed; they have poor spatial judgement, and in particular they confuse left and right, which probably accounts for their poor performance in geography. These characteristics are usually not accompanied by any history of gross neurological disorders, and the EEG may be normal or show only slight abnormalities. There are also a few children who are no good at language skills, and others who have good spatial performance but a poor verbal I.Q. These children often have poor speech development. Again there may be no history of birth trauma: the EEG is often normal and they have no clear neurological disorders. The children therefore present fairly specific educational and psychological problems; they are often temperamentally instable, restless and anxious. But are these essentially psychiatric cases ? Should we not regard their defects as extreme instances of normal abilities linked to individual differences, or are we rather faced with a syndrome of personality disorder? Can we dismiss the cases as examples of ‘adolescent clumsiness’ ? Professor Zangwill suggested that these disabilities do in fact have a neurological
Purification of the scrapie agent by density gradient centrifugation.

R. Marsh,C. Dees,B. Castle,W. Wade,T. German

DOI: https://doi.org/10.1099/0022-1317-65-2-415

1984-02-01

Journal of General Virology

Abstract:Plasma membrane-enriched preparations from scrapie-infected and healthy hamster brains, as well as preparations of neural retina, were sonicated, then separated by rate-zonal sedimentation in 10 to 25% Nycodenz gradients. Gradient fractions were extracted with 0.5% Triton X-100 and re-fractionated by equilibrium density centrifugation in linear 25 to 40% CsCl gradients. Infectivity was highest in a fraction having a density of 1.280 g/ml and which contained a visible band of material. Digestion of the Nycodenz fractions with proteinase K before detergent extraction and CsCl fractionation resulted in a shift in the visible band to a density of 1.235 g/ml with most of the scrapie infectivity remaining at 1.280 g/ml. When labelled with 125I after 40-fold concentration, this 1.280 g/ml CsCl fraction from the proteinase K-treated gradients contained only a single band of protein(s) having a mol. wt. near 30 000. No differences were seen between proteins in healthy or scrapie-infected preparations.
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

Michela Guglieri,Kate Bushby,Michael P McDermott,Kimberly A Hart,Rabi Tawil,William B Martens,Barbara E Herr,Elaine McColl,Chris Speed,Jennifer Wilkinson,Janbernd Kirschner,Wendy M King,Michelle Eagle,Mary W Brown,Tracey Willis,Robert C Griggs,FOR-DMD Investigators of the Muscle Study Group,Volker Straub,Henriette van Ruiten,Anne-Marie Childs,Emma Ciafaloni,Perry B Shieh,Stefan Spinty,Lorenzo Maggi,Giovanni Baranello,Russell J Butterfield,I A Horrocks,Helen Roper,Zoya Alhaswani,Kevin M Flanigan,Nancy L Kuntz,Adnan Manzur,Basil T Darras,Peter B Kang,Leslie Morrison,Monika Krzesniak-Swinarska,Jean K Mah,Tiziana E Mongini,Federica Ricci,Maja von der Hagen,Richard S Finkel,Kathleen O'Reardon,Matthew Wicklund,Ashutosh Kumar,Craig M McDonald,Jay J Han,Nanette Joyce,Erik K Henricson,Ulrike Schara-Schmidt,Andrea Gangfuss,Ekkehard Wilichowski,Richard J Barohn,Jeffrey M Statland,Craig Campbell,Giuseppe Vita,Gian Luca Vita,James F Howard Jr,Imelda Hughes,Hugh J McMillan,Elena Pegoraro,Luca Bello,W Bryan Burnette,Mathula Thangarajh,Taeun Chang

DOI: https://doi.org/10.1001/jama.2022.4315

IF: 11.816

2022-04-19

JAMA

Abstract:Importance: Corticosteroids improve strength and function in boys with Duchenne muscular dystrophy. However, there is uncertainty regarding the optimum regimen and dosage. Objective: To compare efficacy and adverse effects of the 3 most frequently prescribed corticosteroid regimens in boys with Duchenne muscular dystrophy. Design, setting, and participants: Double-blind, parallel-group randomized clinical trial including 196 boys aged 4 to 7 years with Duchenne muscular dystrophy who had not previously been treated with corticosteroids; enrollment occurred between January 30, 2013, and September 17, 2016, at 32 clinic sites in 5 countries. The boys were assessed for 3 years (last participant visit on October 16, 2019). Interventions: Participants were randomized to daily prednisone (0.75 mg/kg) (n = 65), daily deflazacort (0.90 mg/kg) (n = 65), or intermittent prednisone (0.75 mg/kg for 10 days on and then 10 days off) (n = 66). Main outcomes and measures: The global primary outcome comprised 3 end points: rise from the floor velocity (in rise/seconds), forced vital capacity (in liters), and participant or parent global satisfaction with treatment measured by the Treatment Satisfaction Questionnaire for Medication (TSQM; score range, 0 to 100), each averaged across all study visits after baseline. Pairwise group comparisons used a Bonferroni-adjusted significance level of .017. Results: Among the 196 boys randomized (mean age, 5.8 years [SD, 1.0 years]), 164 (84%) completed the trial. Both daily prednisone and daily deflazacort were more effective than intermittent prednisone for the primary outcome (P < .001 for daily prednisone vs intermittent prednisone using a global test; P = .017 for daily deflazacort vs intermittent prednisone using a global test) and the daily regimens did not differ significantly (P = .38 for daily prednisone vs daily deflazacort using a global test). The between-group differences were principally attributable to rise from the floor velocity (0.06 rise/s [98.3% CI, 0.03 to 0.08 rise/s] for daily prednisone vs intermittent prednisone [P = .003]; 0.06 rise/s [98.3% CI, 0.03 to 0.09 rise/s] for daily deflazacort vs intermittent prednisone [P = .017]; and -0.004 rise/s [98.3% CI, -0.03 to 0.02 rise/s] for daily prednisone vs daily deflazacort [P = .75]). The pairwise comparisons for forced vital capacity and TSQM global satisfaction subscale score were not statistically significant. The most common adverse events were abnormal behavior (22 [34%] in the daily prednisone group, 25 [38%] in the daily deflazacort group, and 24 [36%] in the intermittent prednisone group), upper respiratory tract infection (24 [37%], 19 [29%], and 24 [36%], respectively), and vomiting (19 [29%], 17 [26%], and 15 [23%]). Conclusions and relevance: Among patients with Duchenne muscular dystrophy, treatment with daily prednisone or daily deflazacort, compared with intermittent prednisone alternating 10 days on and 10 days off, resulted in significant improvement over 3 years in a composite outcome comprising measures of motor function, pulmonary function, and satisfaction with treatment; there was no significant difference between the 2 daily corticosteroid regimens. The findings support the use of a daily corticosteroid regimen over the intermittent prednisone regimen tested in this study as initial treatment for boys with Duchenne muscular dystrophy. Trial registration: ClinicalTrials.gov Identifier: NCT01603407.
Age-related self-stigma of people over 65 years old: adaptation of the Internalized Stigma of Mental Illness scale (ISMI) for use in age-related self-stigma (IS65+) in a Spanish sample

S. González-Domínguez,M. Muñoz,B. Ausín,M. A. Castellanos,E. Pérez-Santos

DOI: https://doi.org/10.1080/13607863.2016.1247422

2018-02-01

Aging & Mental Health

Abstract:ABSTRACT Objectives: To adapt the Internalized Stigma of Mental Illness scale (ISMI) to examine self-stigma associated with aging and to study the psychometric properties of this adapted version (IS65+). Finally, self-stigma associated with age in older people is studied. Method: The IS65+ was administered to a random sample of 419 people over 65 years from Madrid (Spain) to study the psychometric properties of this adapted version. A regression model was estimated to identify the variables that best predict self-stigma associated with old age. Results: The IS65+ showed good internal consistency (α = .89) and a factorial structure of five factors. The data showed lower levels of self-stigma related to age in the sample than the levels of mental illness self-stigma in people with mental illness. The variables associated with age-related self-stigma are: high levels of perceived loneliness, low levels of coping strategies, gender (female), mental disorder, major depressive disorder, low levels of optimism and quality of life, and high levels of functional impairment. Conclusion: A new version of ISMI (IS65+) with acceptable psychometric criteria has been developed for use in people over 65 years old.
Infrared spectroscopy of biologic materials in aqueous solutions.

E. Blout,H. Lenormant

DOI: https://doi.org/10.1364/JOSA.43.001093

1953-11-01

Journal of the Optical Society of America

Abstract:A technique is described for obtaining the spectra of biologic materials in aqueous media (H2O and D2O) over the frequency range 2000 cm−1 to 700 cm−1. It is now possible to use infrared spectroscopy not only for the identification of substances such as proteins and nucleic acids in their native states, but also to study their reactions and interactions with other materials. Examples are shown of the infrared spectra in aqueous solutions of proteins, nucleic acids, and nucleoproteins, as well as suspensions of living bacteria.
AN ANALYSIS OF SEVERAL FACTORS INFLUENCING INJECTION RATES IN ANGIOGRAPHY.

H. Fischer,G. Roller,P. G. Hubbard

DOI: https://doi.org/10.1148/83.3.396

IF: 19.7

1964-09-01

Radiology

Abstract:The experienced angiographer is presumed to know well his tools. The neophyte, however, may need guidance in the choice of catheter, contrast medium, and injection pressure. The authors have investigated flow rates through small-bore catheters with representative media, since with the increased use of the Seldinger percutaneous technic as well as the wide usage of angiography in children, the smaller caliber angiographic catheters are of great import. Flow through catheters was analyzed in the most rational fashion, namely, in grams of iodine per second. To correct another deficiency of previous studies only contrast media of low toxicity were compared. Last, a much-needed comparison of the capacities of high-pressure injectors was made. Equipment and Methods Contrast Media: The media tested were the low-viscosity Hypaque 50 per cent, medium-viscosity Renovist and Angio-Conray, and the highly viscid Hypaque 90 per cent. Other pertinent physical data for the present-day media are listed in Table I. Fifty p...
Clinical Implications of Routine Monitoring of Pulmonary Function and Ventilation in Patients with Duchenne Muscular Dystrophy

Han Eol Cho,Jang Woo Lee,Won Ah Choi,Seong-Woong Kang

DOI: https://doi.org/10.3349/ymj.2022.63.6.578

Abstract:Purpose: To investigate the effect of regular monitoring of pulmonary function and ventilatory status on the initiation of non-invasive ventilation (NIV) between patients who were routinely monitored before receiving NIV and those who were not. Materials and methods: This retrospective cohort study included subjects with Duchenne muscular dystrophy (DMD) who first received NIV between 2010 and 2019. The subjects were assigned to either the regular-follow-up (REG) group or the non-REG group, according to their follow-up status, before initiating NIV. We compared the number of emergent cases, the results of nocturnal ventilatory monitoring, and the pulmonary function of each group at initial ventilatory support. Results: In total, 73 subjects were enrolled in the REG group and 47 subjects in the non-REG group. There were significantly more emergency cases due to respiratory insufficiency in the non-REG group (12/47, 25.5%) than in the REG group (3/73, 4.1%). At the time of initial ventilatory support, hypoventilatory symptoms were more common and relatively severe in the non-REG group (37/47, 78.7%) than in the REG group (18/73, 24.7%). The average age at initial ventilatory support of the non-REG group was 2.15 years older than that of the subjects in the REG group. Moreover, subjects who were not regularly monitored exhibited greater deterioration in pulmonary function compared to those who were regularly followed up. Conclusion: Regular evaluation of pulmonary function and ventilatory status before the onset of ventilatory insufficiency is crucial to reduce the risk of patients with DMD requiring emergency care due to ventilatory insufficiency.
Author discrimination between the Holy Quran and Prophet's statements

H. Sayoud

DOI: https://doi.org/10.1093/llc/fqs014

2012-12-01

Literary and Linguistic Computing

Abstract:Author discrimination consists of checking whether two texts are written by the same author or not. In this investigation, we try to make an author discrimination between the Quran (The holy words and statements of God in the Islamic religion) and the Hadith (statements said by the prophet Muhammad). The Quran is taken in its entirety, whereas for the Prophet’s statements, we chose only the certified texts of the Bukhari book. Thus, three series of experiments are done and commented on. The first series of experiments analyses the two books in a global form (the text of every book is analyzed as a unique big text). It concerns nine different experiments. The second series of experiments analyses the two books in a segmental form (four different segments of text are extracted from every book). It concerns five different experiments. The third series of experiments makes an automatic authorship attribution of the two books in a segmental form by employing several classifiers and several types of features. The sizes of the segments are more or less in the same range (four different text segments, with approximately the same size, are extracted from every book). It concerns two different experiments. This investigation sheds light on an old enigma, which has not been solved for 14 centuries: in fact, all the results of this investigation have shown that the two books should have two different authors. .................................................................................................................................................................................
Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading

E Landfeldt,A Aleman,S Abner,R Zhang,C Werner,I Tomazos,H Lochmüller,R M Quinlivan

DOI: https://doi.org/10.3233/JND-230094

Abstract:Background: Despite advances in the medical management of the disease, respiratory involvement remains a significant source of morbidity and mortality in children and adults with Duchenne muscular dystrophy (DMD). Objective: The objective of this systematic literature review was to synthesize and grade published evidence of factors associated with respiratory health and function in DMD. Methods: We searched MEDLINE, Embase, and the Cochrane Library for records of studies published from January 1, 2000 (to ensure relevance to current care practices), up until and including December 31, 2022, reporting evidence of prognostic indicators and predictors of disease progression in DMD. The quality of evidence (i.e., very low to high) was assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework. Results: The bibliographic search strategy resulted in the inclusion of 29 articles. In total, evidence of 10 factors associated with respiratory health and function in patients with DMD was identified: glucocorticoid exposure (high- to very low-quality evidence), DMD mutations (low-quality evidence), DMD genetic modifiers (low-quality evidence), other pharmacological interventions (i.e., ataluren, eteplirsen, idebenone, and tamoxifen) (moderate- to very low-quality evidence), body mass index and weight (low-quality evidence), and functional ability (low-quality evidence). Conclusions: In conclusion, we identified a total of 10 factors associated with respiratory health in function in DMD, encompassing both pharmacological therapies, genetic mutations and modifiers, and patient clinical characteristics. Yet, more research is needed to further delineate sources of respiratory heterogeneity, in particular the genotype-phenotype association and the impact of novel DMD therapies in a real-world setting. Our synthesis and grading should be helpful to inform clinical practice and future research of this heavily burdened patient population.

The classification of depressions.

Understanding the experiences of lung volume recruitment among boys with Duchenne muscular dystrophy: A multicenter qualitative study

Duplex ultrasound evaluation of patients with chronic venous disease of the lower extremities.

Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy

EFFECTS OF NA OPTIMIZED APPROACH TO HOME-BASED RESPIRATORY CARE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY: STUDY PROTOCOL FOR CLINICAL TRIAL

Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy: A Single-Site Retrospective Longitudinal Study

Respiratory Function and Sleep Disordered Breathing in Pediatric Duchenne Muscular Dystrophy

Lung volume recruitment improves volitional airway clearance in amyotrophic lateral sclerosis

Brainstem neurons expressing c-Fos immunoreactivity following irritant chemical stimulation of the rat's tongue

Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience

Non-invasive ventilation usage and adherence in children and adults with Duchenne muscular dystrophy: A multicenter analysis

A new structure for VLSI bipolar technology

Problems in Child Neurology and Psychology

Purification of the scrapie agent by density gradient centrifugation.

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

Age-related self-stigma of people over 65 years old: adaptation of the Internalized Stigma of Mental Illness scale (ISMI) for use in age-related self-stigma (IS65+) in a Spanish sample

Infrared spectroscopy of biologic materials in aqueous solutions.

AN ANALYSIS OF SEVERAL FACTORS INFLUENCING INJECTION RATES IN ANGIOGRAPHY.

Clinical Implications of Routine Monitoring of Pulmonary Function and Ventilation in Patients with Duchenne Muscular Dystrophy

Author discrimination between the Holy Quran and Prophet's statements

Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading